Michael L. Kaufman

Michael L. Kaufman

Auto-generated profile, based on publicly available information

Michael L. Kaufman

University of Colorado Anschutz Medical Campus 1 Department of Ophthalmology Aurora, CO 80045

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2015 in Blood
Verified
Journal Article
Open access
PDF file
MHMegan D. Hoban
Megan D. Hoban
GCGregory J. Cost
Gregory J. Cost
MMMatthew C. Mendel
Matthew C. Mendel
ZRZulema Romero
Zulema Romero
MKMichael L. Kaufman
Michael L. Kaufman
DKDonald Kohn
Donald Kohn
Key Points: Delivery of ZFNs and donor templates results in high levels of gene correction in human CD34+ cells from multiple sources, including SCD BM. Modified CD34+ cells are capable of engrafting immunocompromised NSG mice and produce cells from multiple lineages.

18 June 2021 in Development
Verified
Journal Article
Open access
PDF file
MKMichael L. Kaufman
Michael L. Kaufman
NGNoah B. Goodson
Noah B. Goodson
KPKo Uoon Park
Ko Uoon Park
MSMichael Schwanke
Michael Schwanke
EOEmma Office
Emma Office
JBJoseph A. Brzezinski
Joseph A. Brzezinski
During retinal development, a large subset of progenitors upregulates the transcription factor Otx2, which is required for photoreceptor and bipolar cell formation. How these retinal progenitor cells initially activate Otx2 expression is unclear. To address this, we investigated the cis-regulatory network that controls Otx2 expression in mice. We identified a minimal enhancer element, DHS-4D, that drove expression in newly formed OTX2+ cells. CRISPR/Cas9-mediated deletion of DHS-4D reduced OTX2 expression, but this effect was diminished in postnatal development. Systematic mutagenesis of the enhancer revealed that three basic helix-loop-helix (bHLH) transcription factor-binding sites were required for its activity. Single cell RNA-sequencing of nascent Otx2+ cells identified the bHLH factors Ascl1 and Neurog2 as candidate regulators. CRISPR/Cas9 targeting of these factors showed that only the simultaneous loss of Ascl1 and Neurog2 prevented OTX2 expression. Our findings suggest that Ascl1 and Neurog2 act either redundantly or in a compensatory fashion to activate the DHS-4D enhancer and Otx2 expression. We observed redundancy or compensation at both the transcriptional and enhancer utilization levels, suggesting that the mechanisms governing Otx2 regulation in the retina are flexible and robust.

25 October 2023 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
RFRui Fu
Rui Fu
KWKathryn Walters
Kathryn Walters
MKMichael L Kaufman
Michael L Kaufman
KKKatrina Koc
Katrina Koc
ABAmber Baldwin
Amber Baldwin
NMNeelanjan Mukherjee
Neelanjan Mukherjee
The human adrenal gland consists of concentrically organized, functionally distinct regions responsible for hormone production. Dysregulation of adrenocortical cell differentiation alters the proportion and organization of the functional zones of the adrenal cortex leading to disease. Current models of adrenocortical cell differentiation are based on mouse studies, but there are known organizational and functional differences between human and mouse adrenal glands. This study aimed to investigate the centripetal differentiation model in the human adrenal cortex and characterize aldosterone-producing micronodules (APMs) to better understand adrenal diseases such as primary aldosteronism. We applied spatially resolved in situ transcriptomics to human adrenal tissue sections from 2 individuals and identified distinct cell populations and their positional relationships. The results supported the centripetal differentiation model in humans, with cells progressing from the outer capsule to the zona glomerulosa, zona fasciculata, and zona reticularis. Additionally, we characterized 2 APMs in a 72-year-old woman. Comparison with earlier APM transcriptomes indicated a subset of core genes, but also heterogeneity between APMs. The findings contribute to our understanding of normal and pathological cellular differentiation in the human adrenal cortex.

15 March 2026 in Development
Verified
Journal Article
Open access
PDF file
IPIan Purvis
Ian Purvis
OOOmar E. Ochoa Olmos
Omar E. Ochoa Olmos
KPKo Uoon Park
Ko Uoon Park
MKMichael L. Kaufman
Michael L. Kaufman
CHCharles M. Henry
Charles M. Henry
JBJoseph A. Brzezinski
Joseph A. Brzezinski
The transcription factor Otx2 is essential for photoreceptor and bipolar cell formation during retinal development. Otx2 expression is complex and underlies multiple cell fate decisions during development. To understand how Otx2 expression is regulated, we explored the activity and function of three of its enhancers (DHS2, DHS4 and DHS15). Enhancer reporter assays and lineage tracing show that DHS4 initiates Otx2 expression while DHS2 and DHS15 maintain expression in photoreceptors. Matched CRISPR/Cas9 and CRISPR interference systems were used to mutate or epigenetically silence enhancers, respectively. CRISPR reduced OTX2 expression acutely, but failed to significantly alter cell fate choice over the long term. In contrast, CRISPR interference of these enhancers caused permanent OTX2 loss and corresponding cell fate changes. While these data suggest that each enhancer is needed for normal Otx2 expression, it also highlights that the enhancers can interact and substitute for each other during development. This cis-regulatory element flexibility likely promotes Otx2 expression robustness. Such robustness may enable complex genes, like Otx2, to resist environmental stressors and regulatory disruptions to promote reproducible developmental outcomes.